BCMAS FINAL EXAM 2026 QUESTIONS AND ANSWERS
SURE A+
✔✔What best describes a disease-specific instrument used to measure Health Related-
Quality of Life (HR-QOL)? - ✔✔it is more sensitive and focuses on a specific treatment
or disease impact
✔✔Which law directed the NIH to include women and minorities in clinical research? -
✔✔NIH Revitalization Act of 1993
✔✔What do studies under the category of Post-Marketing requirements (PMRs) usually
address? - ✔✔safety concerns of drugs
✔✔Which of the following is regulated by OPDP? - ✔✔printed prescription drug
promotional materials
✔✔What is the primary goal of medical affairs? - ✔✔Objectively present data that may
provide evidence to support the current indication or indications that are "off label"
✔✔T/F: The European Union Reference Dates (EURD) is updated on an ongoing basis.
- ✔✔True
✔✔What types of testing can take place at the Pre-Clinical Research phase? - ✔✔in
vitro testing
in vivo testing
✔✔Prior to the publication approval, which department(s) need to approve the abstract,
poster, oral presentation, and/or manuscript? - ✔✔Clinical
Regulatory
Legal
✔✔Which phase of Clinical Trials involves the largest number of participants? -
✔✔Phase III
✔✔T/F: MSLs cannot aid in clinical trial design of corporately run studies, as well as
investigator-initiated studies. - ✔✔False
✔✔What is seen as a disadvantage of point-of-care (POC) diagnostics? - ✔✔training is
required
✔✔Which of the following best describes the grant for fellowship funding? -
✔✔Educational grants
,✔✔A proactive interaction between a pharma representative and HCP takes place
when: - ✔✔The pharma company representative initiates the interaction to provide
product information to the HCP
✔✔What term is used to describe an unpleasant and unintended response to any dose
of a drug or biologic product where there is a possibility that the product caused the
response? - ✔✔Suspected adverse drug reaction
✔✔Which of the following regulates prescription drug promotional labeling? - ✔✔OPDP
✔✔What best describes a health status assessment? - ✔✔A self-assessment that
measures multiple aspects of a patient's perceived well-being
✔✔An MSL on your team provides a speaker honorarium in exchange for the
healthcare provider to write at least 5 prescriptions per week of their newly approved
drug. Which of the following is true? - ✔✔This violates the anti-kickback statute
✔✔Which classification would be needed for IVD products that are considered high risk
? - ✔✔Class III (general controls and premarket approval)
✔✔Heart is a medical device company that has a newly approved pacemaker on the
market, and it is being monitored for any concerns. Which step of the device
development process is this considered? - ✔✔FDA post-market safety monitoring
✔✔T/F: The medical affairs team develops the clinical protocol for the study. - ✔✔True
✔✔What types of meals are appropriate during representatives' interactions with HCPs?
- ✔✔Moderately-priced meals.
Meals in a hospital or in-office setting.
✔✔T/F: An MSL from a pharmaceutical company provides an educational program for
cardiologists about a new cholesterol medication at a football game. This is considered
an appropriate interaction. - ✔✔False
✔✔The type of selection bias that occurs when the enrolled cohort differs from the
general population from which they were drawn is often referred to as ________ bias. -
✔✔volunteer
✔✔Which statements are true about FDA approvals for medical devices? - ✔✔Requires
clinical proof of safety.
Requires a complete application and full review of technical and clinical details.
, Is issued for new devices where a predicate device does not exist for comparison
✔✔Which law requires manufacturers to demonstrate that drugs are safe and effective
before they are marketed? - ✔✔Kefauver-Harris Amendments
✔✔To avoid serious infection because of a drug or class of drugs, which FDA safety
measure should be put into place? - ✔✔Patient education of initial warning signs of
infection prior to prescribing
✔✔When should companies start preparing for a product launch? - ✔✔12-24 months
before launch
✔✔Which of the following best describes the investigator's responsibilities? -
✔✔Assumes all responsibilities for complying with regulatory requirements
✔✔Which of the items listed below would be an appropriate educational gift that an
MSL could give to an HCP? - ✔✔Educational items that could be used in a patient
examination room, such as anatomical models
✔✔Which of the following is true regarding systematic reviews? - ✔✔Qualitative
summaries
Reporting bias is considered a limitation
✔✔In what year were the first GPP guidelines published? - ✔✔2003
✔✔You are on the Medical Affairs team. While in the Post-Marketing studies, your
company has discovered a potential label change for the drug being studied. What is
your team's role in this process? - ✔✔Meet with regulators regarding the label change
Work cross-functionally with your Regulatory and Commercial teams to ensure accurate
data for a label change
✔✔T/F: The primary function of an advisory board is to offer trusted advice on various
issues for the company. - ✔✔True
✔✔example of a Class I device - ✔✔dental floss
✔✔Why is the diagnostic industry now able to expand its focus to the diagnosis of more
rare diseases? - ✔✔Ability to identify patient responders through pharmacogenomics
✔✔Which of the following are primary pharmaceutical regulators in the United States? -
✔✔FDA
SURE A+
✔✔What best describes a disease-specific instrument used to measure Health Related-
Quality of Life (HR-QOL)? - ✔✔it is more sensitive and focuses on a specific treatment
or disease impact
✔✔Which law directed the NIH to include women and minorities in clinical research? -
✔✔NIH Revitalization Act of 1993
✔✔What do studies under the category of Post-Marketing requirements (PMRs) usually
address? - ✔✔safety concerns of drugs
✔✔Which of the following is regulated by OPDP? - ✔✔printed prescription drug
promotional materials
✔✔What is the primary goal of medical affairs? - ✔✔Objectively present data that may
provide evidence to support the current indication or indications that are "off label"
✔✔T/F: The European Union Reference Dates (EURD) is updated on an ongoing basis.
- ✔✔True
✔✔What types of testing can take place at the Pre-Clinical Research phase? - ✔✔in
vitro testing
in vivo testing
✔✔Prior to the publication approval, which department(s) need to approve the abstract,
poster, oral presentation, and/or manuscript? - ✔✔Clinical
Regulatory
Legal
✔✔Which phase of Clinical Trials involves the largest number of participants? -
✔✔Phase III
✔✔T/F: MSLs cannot aid in clinical trial design of corporately run studies, as well as
investigator-initiated studies. - ✔✔False
✔✔What is seen as a disadvantage of point-of-care (POC) diagnostics? - ✔✔training is
required
✔✔Which of the following best describes the grant for fellowship funding? -
✔✔Educational grants
,✔✔A proactive interaction between a pharma representative and HCP takes place
when: - ✔✔The pharma company representative initiates the interaction to provide
product information to the HCP
✔✔What term is used to describe an unpleasant and unintended response to any dose
of a drug or biologic product where there is a possibility that the product caused the
response? - ✔✔Suspected adverse drug reaction
✔✔Which of the following regulates prescription drug promotional labeling? - ✔✔OPDP
✔✔What best describes a health status assessment? - ✔✔A self-assessment that
measures multiple aspects of a patient's perceived well-being
✔✔An MSL on your team provides a speaker honorarium in exchange for the
healthcare provider to write at least 5 prescriptions per week of their newly approved
drug. Which of the following is true? - ✔✔This violates the anti-kickback statute
✔✔Which classification would be needed for IVD products that are considered high risk
? - ✔✔Class III (general controls and premarket approval)
✔✔Heart is a medical device company that has a newly approved pacemaker on the
market, and it is being monitored for any concerns. Which step of the device
development process is this considered? - ✔✔FDA post-market safety monitoring
✔✔T/F: The medical affairs team develops the clinical protocol for the study. - ✔✔True
✔✔What types of meals are appropriate during representatives' interactions with HCPs?
- ✔✔Moderately-priced meals.
Meals in a hospital or in-office setting.
✔✔T/F: An MSL from a pharmaceutical company provides an educational program for
cardiologists about a new cholesterol medication at a football game. This is considered
an appropriate interaction. - ✔✔False
✔✔The type of selection bias that occurs when the enrolled cohort differs from the
general population from which they were drawn is often referred to as ________ bias. -
✔✔volunteer
✔✔Which statements are true about FDA approvals for medical devices? - ✔✔Requires
clinical proof of safety.
Requires a complete application and full review of technical and clinical details.
, Is issued for new devices where a predicate device does not exist for comparison
✔✔Which law requires manufacturers to demonstrate that drugs are safe and effective
before they are marketed? - ✔✔Kefauver-Harris Amendments
✔✔To avoid serious infection because of a drug or class of drugs, which FDA safety
measure should be put into place? - ✔✔Patient education of initial warning signs of
infection prior to prescribing
✔✔When should companies start preparing for a product launch? - ✔✔12-24 months
before launch
✔✔Which of the following best describes the investigator's responsibilities? -
✔✔Assumes all responsibilities for complying with regulatory requirements
✔✔Which of the items listed below would be an appropriate educational gift that an
MSL could give to an HCP? - ✔✔Educational items that could be used in a patient
examination room, such as anatomical models
✔✔Which of the following is true regarding systematic reviews? - ✔✔Qualitative
summaries
Reporting bias is considered a limitation
✔✔In what year were the first GPP guidelines published? - ✔✔2003
✔✔You are on the Medical Affairs team. While in the Post-Marketing studies, your
company has discovered a potential label change for the drug being studied. What is
your team's role in this process? - ✔✔Meet with regulators regarding the label change
Work cross-functionally with your Regulatory and Commercial teams to ensure accurate
data for a label change
✔✔T/F: The primary function of an advisory board is to offer trusted advice on various
issues for the company. - ✔✔True
✔✔example of a Class I device - ✔✔dental floss
✔✔Why is the diagnostic industry now able to expand its focus to the diagnosis of more
rare diseases? - ✔✔Ability to identify patient responders through pharmacogenomics
✔✔Which of the following are primary pharmaceutical regulators in the United States? -
✔✔FDA
